Global Home Hemodialysis Market

Home Hemodialysis Comprehensive Study by Type (Hemodialysis, Peritoneal Dialysis, Device, Consumables, Others), Application (Drug Store, On-line), Treatment (Acute Kidney Disease, Chronic Kidney Disease), Portability (Benchtop Machines, Trolley Based Machines) Players and Region - Global Market Outlook to 2028

Home Hemodialysis Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Home Hemodialysis?
Home Hemodialysis (HHD) is the provision of hemodialysis in the home of a person whose kidneys are not functioning normally. One advantage of doing dialysis at home is that it can be done more frequently and slowly, reducing the washed-out feeling and other symptoms caused by rapid ultrafiltration, and it can often be done at night while the person is sleeping. People on home hemodialysis are prescribed dialysis by a nephrologist and rely on the support of a dialysis unit for backup treatments and case management. HHD improves patients' sense of well-being, the more they understand and control their own treatment, the better they will do on dialysis.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledBecton, Dickinson and Company (United States), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Baxter International Inc. (United States), Braun Melsungen AG (Germany), MEDTRONIC PUBLIC LIMITED COMPANY (Ireland), Nipro Corporation (Japan), Toray Industries, Inc. (Japan) and Quanta Dialysis Technologies (United Kingdom)


The study covers a detailed analysis segmented by key business segments i.e. by type (Hemodialysis, Peritoneal Dialysis, Device, Consumables and Others) , by application (Drug Store and On-line) and major geographies. Research Analyst at AMA predicts that United States & German Players will contribute to the maximum growth of Global Home Hemodialysis market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Home Hemodialysis market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Becton, Dickinson and Company (United States), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Baxter International Inc. (United States), Braun Melsungen AG (Germany), MEDTRONIC PUBLIC LIMITED COMPANY (Ireland), Nipro Corporation (Japan), Toray Industries, Inc. (Japan) and Quanta Dialysis Technologies (United Kingdom).

Market Overview:
On 7th April 2022, Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNFs), is pleased to announce that it has completed its announced acquisition of Compass Home Dialysis, a regional dialysis provider in Pennsylvania with on-site dialysis services in nine SNFs, as well as an outpatient dialysis clinic.
Centers for Medicare & Medicaid Services (CMS) Survey and Certification Program certifies ESRD facilities for Medicare Program inclusion by validating that each facility's care and services meet specified safety and quality standards known as Conditions for Coverage. The CMS Dialysis Page provides ESRD surveyors and dialysis providers with basic information about surveying and certifying dialysis facilities. It contains links to applicable laws and regulations as well as resources to help support and assess compliance with federal regulations.
The Home Hemodialysis market is highly diversified and competitive with a large number of players. Tier-I firms, mid-tier firms, and start-up firms are among the market participants. In this highly competitive market, businesses are attempting to gain market visibility. Furthermore, due to the high capital requirements for manufacturing and marketing products as well as the time-consuming regulatory approval process, many companies (particularly start-ups and small businesses) struggle to survive and keep up with the industry's growth. This can be a significant barrier for a company to develop a long-term innovation capability across all market segments.

Influencing Trend:
Demand for Home Hemodialysis Is Increasing

Market Growth Drivers:
Increase in the Prevalence of End-Stage Renal Disease (ESRD), Increasing Prevalence of Blood and Blood-Related Infections and Chronic Kidney Disease (CKD) and Increase in Elderly Population

Challenges:
Installation of a Maintenance Hemodialysis (MHD) Unit and Small and Medium-Sized Businesses' Survival in A Highly Competitive Market

Restraints:
Adverse Effects of Poor Hygiene and Repeated Hemodialysis, Dialysis-Related Risks and Complications and Complications and Risks Associated With Dialysis

Opportunities:
Unmet Demand Is Expected To Drive the Global Hemodialysis Chairs Market during the Forecast Period and Increased Awareness of Various Types of Infections in Developing Countries

Key highlights of the Global Home Hemodialysis market Study:
• CAGR of the market during the forecast period 2022-2028
• In-depth information on growth factors that will accelerate the Home Hemodialysis market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Home Hemodialysis market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Home Hemodialysis Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Home Hemodialysis market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Home Hemodialysis market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Venture and Capitalist, Home Hemodialysis Distributor & Suppliers, Corporate Entities, Government Research Organizations, Private Research Organization, Government Bodies, End-Users and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Hemodialysis
  • Peritoneal Dialysis
  • Device
  • Consumables
  • Others
By Application
  • Drug Store
  • On-line
By Treatment
  • Acute Kidney Disease
  • Chronic Kidney Disease

By Portability
  • Benchtop Machines
  • Trolley Based Machines

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Prevalence of End-Stage Renal Disease (ESRD)
      • 3.2.2. Increasing Prevalence of Blood and Blood-Related Infections and Chronic Kidney Disease (CKD)
      • 3.2.3. Increase in Elderly Population
    • 3.3. Market Challenges
      • 3.3.1. Installation of a Maintenance Hemodialysis (MHD) Unit
      • 3.3.2. Small and Medium-Sized Businesses' Survival in A Highly Competitive Market
    • 3.4. Market Trends
      • 3.4.1. Demand for Home Hemodialysis Is Increasing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Home Hemodialysis, by Type, Application, Treatment, Portability and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Home Hemodialysis (Value)
      • 5.2.1. Global Home Hemodialysis by: Type (Value)
        • 5.2.1.1. Hemodialysis
        • 5.2.1.2. Peritoneal Dialysis
        • 5.2.1.3. Device
        • 5.2.1.4. Consumables
        • 5.2.1.5. Others
      • 5.2.2. Global Home Hemodialysis by: Application (Value)
        • 5.2.2.1. Drug Store
        • 5.2.2.2. On-line
      • 5.2.3. Global Home Hemodialysis by: Treatment (Value)
        • 5.2.3.1. Acute Kidney Disease
        • 5.2.3.2. Chronic Kidney Disease
      • 5.2.4. Global Home Hemodialysis by: Portability (Value)
        • 5.2.4.1. Benchtop Machines
        • 5.2.4.2. Trolley Based Machines
      • 5.2.5. Global Home Hemodialysis Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Home Hemodialysis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dialife SA (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Fresenius Medical Care AG & Co. KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asahi Kasei Medical Co., Ltd. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Baxter International Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Braun Melsungen AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MEDTRONIC PUBLIC LIMITED COMPANY (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nipro Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Toray Industries, Inc. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Quanta Dialysis Technologies (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Home Hemodialysis Sale, by Type, Application, Treatment, Portability and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Home Hemodialysis (Value)
      • 7.2.1. Global Home Hemodialysis by: Type (Value)
        • 7.2.1.1. Hemodialysis
        • 7.2.1.2. Peritoneal Dialysis
        • 7.2.1.3. Device
        • 7.2.1.4. Consumables
        • 7.2.1.5. Others
      • 7.2.2. Global Home Hemodialysis by: Application (Value)
        • 7.2.2.1. Drug Store
        • 7.2.2.2. On-line
      • 7.2.3. Global Home Hemodialysis by: Treatment (Value)
        • 7.2.3.1. Acute Kidney Disease
        • 7.2.3.2. Chronic Kidney Disease
      • 7.2.4. Global Home Hemodialysis by: Portability (Value)
        • 7.2.4.1. Benchtop Machines
        • 7.2.4.2. Trolley Based Machines
      • 7.2.5. Global Home Hemodialysis Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Home Hemodialysis: by Type(USD Million)
  • Table 2. Home Hemodialysis Hemodialysis , by Region USD Million (2017-2022)
  • Table 3. Home Hemodialysis Peritoneal Dialysis , by Region USD Million (2017-2022)
  • Table 4. Home Hemodialysis Device , by Region USD Million (2017-2022)
  • Table 5. Home Hemodialysis Consumables , by Region USD Million (2017-2022)
  • Table 6. Home Hemodialysis Others , by Region USD Million (2017-2022)
  • Table 7. Home Hemodialysis: by Application(USD Million)
  • Table 8. Home Hemodialysis Drug Store , by Region USD Million (2017-2022)
  • Table 9. Home Hemodialysis On-line , by Region USD Million (2017-2022)
  • Table 10. Home Hemodialysis: by Treatment(USD Million)
  • Table 11. Home Hemodialysis Acute Kidney Disease , by Region USD Million (2017-2022)
  • Table 12. Home Hemodialysis Chronic Kidney Disease , by Region USD Million (2017-2022)
  • Table 13. Home Hemodialysis: by Portability(USD Million)
  • Table 14. Home Hemodialysis Benchtop Machines , by Region USD Million (2017-2022)
  • Table 15. Home Hemodialysis Trolley Based Machines , by Region USD Million (2017-2022)
  • Table 16. South America Home Hemodialysis, by Country USD Million (2017-2022)
  • Table 17. South America Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 18. South America Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 19. South America Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 20. South America Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 21. Brazil Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 22. Brazil Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 23. Brazil Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 24. Brazil Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 25. Argentina Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 26. Argentina Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 27. Argentina Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 28. Argentina Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 29. Rest of South America Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 32. Rest of South America Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 33. Asia Pacific Home Hemodialysis, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 37. Asia Pacific Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 38. China Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 39. China Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 40. China Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 41. China Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 42. Japan Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 43. Japan Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 44. Japan Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 45. Japan Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 46. India Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 47. India Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 48. India Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 49. India Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 50. South Korea Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 51. South Korea Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 52. South Korea Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 53. South Korea Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 54. Australia Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 55. Australia Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 56. Australia Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 57. Australia Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 58. Rest of Asia-Pacific Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 60. Rest of Asia-Pacific Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 62. Europe Home Hemodialysis, by Country USD Million (2017-2022)
  • Table 63. Europe Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 64. Europe Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 65. Europe Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 66. Europe Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 67. Germany Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 68. Germany Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 69. Germany Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 70. Germany Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 71. France Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 72. France Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 73. France Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 74. France Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 75. Italy Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 76. Italy Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 77. Italy Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 78. Italy Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 79. United Kingdom Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 80. United Kingdom Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 81. United Kingdom Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 82. United Kingdom Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 83. Netherlands Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 84. Netherlands Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 85. Netherlands Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 86. Netherlands Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 87. Rest of Europe Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 88. Rest of Europe Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 89. Rest of Europe Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 90. Rest of Europe Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 91. MEA Home Hemodialysis, by Country USD Million (2017-2022)
  • Table 92. MEA Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 93. MEA Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 94. MEA Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 95. MEA Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 96. Middle East Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 97. Middle East Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 98. Middle East Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 99. Middle East Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 100. Africa Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 101. Africa Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 102. Africa Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 103. Africa Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 104. North America Home Hemodialysis, by Country USD Million (2017-2022)
  • Table 105. North America Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 106. North America Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 107. North America Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 108. North America Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 109. United States Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 110. United States Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 111. United States Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 112. United States Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 113. Canada Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 114. Canada Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 115. Canada Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 116. Canada Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 117. Mexico Home Hemodialysis, by Type USD Million (2017-2022)
  • Table 118. Mexico Home Hemodialysis, by Application USD Million (2017-2022)
  • Table 119. Mexico Home Hemodialysis, by Treatment USD Million (2017-2022)
  • Table 120. Mexico Home Hemodialysis, by Portability USD Million (2017-2022)
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Home Hemodialysis: by Type(USD Million)
  • Table 132. Home Hemodialysis Hemodialysis , by Region USD Million (2023-2028)
  • Table 133. Home Hemodialysis Peritoneal Dialysis , by Region USD Million (2023-2028)
  • Table 134. Home Hemodialysis Device , by Region USD Million (2023-2028)
  • Table 135. Home Hemodialysis Consumables , by Region USD Million (2023-2028)
  • Table 136. Home Hemodialysis Others , by Region USD Million (2023-2028)
  • Table 137. Home Hemodialysis: by Application(USD Million)
  • Table 138. Home Hemodialysis Drug Store , by Region USD Million (2023-2028)
  • Table 139. Home Hemodialysis On-line , by Region USD Million (2023-2028)
  • Table 140. Home Hemodialysis: by Treatment(USD Million)
  • Table 141. Home Hemodialysis Acute Kidney Disease , by Region USD Million (2023-2028)
  • Table 142. Home Hemodialysis Chronic Kidney Disease , by Region USD Million (2023-2028)
  • Table 143. Home Hemodialysis: by Portability(USD Million)
  • Table 144. Home Hemodialysis Benchtop Machines , by Region USD Million (2023-2028)
  • Table 145. Home Hemodialysis Trolley Based Machines , by Region USD Million (2023-2028)
  • Table 146. South America Home Hemodialysis, by Country USD Million (2023-2028)
  • Table 147. South America Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 148. South America Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 149. South America Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 150. South America Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 151. Brazil Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 152. Brazil Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 153. Brazil Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 154. Brazil Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 155. Argentina Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 156. Argentina Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 157. Argentina Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 158. Argentina Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 159. Rest of South America Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 160. Rest of South America Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 161. Rest of South America Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 162. Rest of South America Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 163. Asia Pacific Home Hemodialysis, by Country USD Million (2023-2028)
  • Table 164. Asia Pacific Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 165. Asia Pacific Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 166. Asia Pacific Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 167. Asia Pacific Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 168. China Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 169. China Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 170. China Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 171. China Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 172. Japan Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 173. Japan Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 174. Japan Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 175. Japan Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 176. India Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 177. India Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 178. India Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 179. India Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 180. South Korea Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 181. South Korea Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 182. South Korea Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 183. South Korea Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 184. Australia Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 185. Australia Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 186. Australia Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 187. Australia Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 188. Rest of Asia-Pacific Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 189. Rest of Asia-Pacific Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 190. Rest of Asia-Pacific Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 191. Rest of Asia-Pacific Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 192. Europe Home Hemodialysis, by Country USD Million (2023-2028)
  • Table 193. Europe Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 194. Europe Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 195. Europe Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 196. Europe Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 197. Germany Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 198. Germany Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 199. Germany Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 200. Germany Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 201. France Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 202. France Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 203. France Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 204. France Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 205. Italy Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 206. Italy Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 207. Italy Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 208. Italy Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 209. United Kingdom Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 210. United Kingdom Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 211. United Kingdom Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 212. United Kingdom Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 213. Netherlands Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 214. Netherlands Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 215. Netherlands Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 216. Netherlands Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 217. Rest of Europe Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 218. Rest of Europe Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 219. Rest of Europe Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 220. Rest of Europe Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 221. MEA Home Hemodialysis, by Country USD Million (2023-2028)
  • Table 222. MEA Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 223. MEA Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 224. MEA Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 225. MEA Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 226. Middle East Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 227. Middle East Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 228. Middle East Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 229. Middle East Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 230. Africa Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 231. Africa Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 232. Africa Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 233. Africa Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 234. North America Home Hemodialysis, by Country USD Million (2023-2028)
  • Table 235. North America Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 236. North America Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 237. North America Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 238. North America Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 239. United States Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 240. United States Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 241. United States Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 242. United States Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 243. Canada Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 244. Canada Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 245. Canada Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 246. Canada Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 247. Mexico Home Hemodialysis, by Type USD Million (2023-2028)
  • Table 248. Mexico Home Hemodialysis, by Application USD Million (2023-2028)
  • Table 249. Mexico Home Hemodialysis, by Treatment USD Million (2023-2028)
  • Table 250. Mexico Home Hemodialysis, by Portability USD Million (2023-2028)
  • Table 251. Research Programs/Design for This Report
  • Table 252. Key Data Information from Secondary Sources
  • Table 253. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Home Hemodialysis: by Type USD Million (2017-2022)
  • Figure 5. Global Home Hemodialysis: by Application USD Million (2017-2022)
  • Figure 6. Global Home Hemodialysis: by Treatment USD Million (2017-2022)
  • Figure 7. Global Home Hemodialysis: by Portability USD Million (2017-2022)
  • Figure 8. South America Home Hemodialysis Share (%), by Country
  • Figure 9. Asia Pacific Home Hemodialysis Share (%), by Country
  • Figure 10. Europe Home Hemodialysis Share (%), by Country
  • Figure 11. MEA Home Hemodialysis Share (%), by Country
  • Figure 12. North America Home Hemodialysis Share (%), by Country
  • Figure 13. Global Home Hemodialysis share by Players 2022 (%)
  • Figure 14. Global Home Hemodialysis share by Players (Top 3) 2022(%)
  • Figure 15. Global Home Hemodialysis share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 19. Dialife SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Dialife SA (Switzerland) Revenue: by Geography 2022
  • Figure 21. Fresenius Medical Care AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Fresenius Medical Care AG & Co. KGaA (Germany) Revenue: by Geography 2022
  • Figure 23. Asahi Kasei Medical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Asahi Kasei Medical Co., Ltd. (Japan) Revenue: by Geography 2022
  • Figure 25. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Baxter International Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 29. MEDTRONIC PUBLIC LIMITED COMPANY (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. MEDTRONIC PUBLIC LIMITED COMPANY (Ireland) Revenue: by Geography 2022
  • Figure 31. Nipro Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Nipro Corporation (Japan) Revenue: by Geography 2022
  • Figure 33. Toray Industries, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Toray Industries, Inc. (Japan) Revenue: by Geography 2022
  • Figure 35. Quanta Dialysis Technologies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Quanta Dialysis Technologies (United Kingdom) Revenue: by Geography 2022
  • Figure 37. Global Home Hemodialysis: by Type USD Million (2023-2028)
  • Figure 38. Global Home Hemodialysis: by Application USD Million (2023-2028)
  • Figure 39. Global Home Hemodialysis: by Treatment USD Million (2023-2028)
  • Figure 40. Global Home Hemodialysis: by Portability USD Million (2023-2028)
  • Figure 41. South America Home Hemodialysis Share (%), by Country
  • Figure 42. Asia Pacific Home Hemodialysis Share (%), by Country
  • Figure 43. Europe Home Hemodialysis Share (%), by Country
  • Figure 44. MEA Home Hemodialysis Share (%), by Country
  • Figure 45. North America Home Hemodialysis Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Dialife SA (Switzerland)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Baxter International Inc. (United States)
  • Braun Melsungen AG (Germany)
  • MEDTRONIC PUBLIC LIMITED COMPANY (Ireland)
  • Nipro Corporation (Japan)
  • Toray Industries, Inc. (Japan)
  • Quanta Dialysis Technologies (United Kingdom)
Additional players considered in the study are as follows:
Nikkiso Co., Ltd. (Japan) , DaVita Inc. (United States) , Cantel Medical Corporation (United States) , Others
Select User Access Type

Key Highlights of Report


Dec 2023 213 Pages 64 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Home Hemodialysis Market Quantitative research analysis
Global Home Hemodialysis Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Home Hemodialysis Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Home Hemodialysis market is dominated by United States & German Players and may generate healthy valuation by 2028.
  • Increase in the Prevalence of End-Stage Renal Disease (ESRD)
  • Increasing Prevalence of Blood and Blood-Related Infections and Chronic Kidney Disease (CKD)
  • Increase in Elderly Population
dominated the Home Hemodialysis market. This is attributable to growing trend of "Demand for Home Hemodialysis Is Increasing"

Know More About Global Home Hemodialysis Market Report?

Have a Query? Click Here

Other Related Reports

Oncology Clinical Trials Comprehensive Study by Design (Observational Studies, Treatment Studies), Phase (Phase I, Phase II, Phase III), Cancer (Lung Cancer, Breast Cancer, Thyroid Cancer, Leukemia, ...
$ 3500
Systemic Lupus Erythematosus Treatment Comprehensive Study by Type (Hydroxychloroquine, Nonsteroidal Anti-Inflammatory Medications (NSAIDS), Steroids), End users (Hospitals, Clinics, Others), Body Pa...
$ 3800